Diana Giannarelli

25.0k total citations · 2 hit papers
604 papers, 13.2k citations indexed

About

Diana Giannarelli is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Diana Giannarelli has authored 604 papers receiving a total of 13.2k indexed citations (citations by other indexed papers that have themselves been cited), including 309 papers in Oncology, 166 papers in Pulmonary and Respiratory Medicine and 91 papers in Surgery. Recurrent topics in Diana Giannarelli's work include Cancer Immunotherapy and Biomarkers (84 papers), Cancer Treatment and Pharmacology (76 papers) and Chronic Lymphocytic Leukemia Research (63 papers). Diana Giannarelli is often cited by papers focused on Cancer Immunotherapy and Biomarkers (84 papers), Cancer Treatment and Pharmacology (76 papers) and Chronic Lymphocytic Leukemia Research (63 papers). Diana Giannarelli collaborates with scholars based in Italy, Malaysia and United States. Diana Giannarelli's co-authors include Francesco Cognetti, Emilio Bria, Michèle Milella, Paolo Carlini, Paolo A. Ascierto, Federica Cuppone, Isabella Sperduti, Alessandra Fabi, Michele Maio and Anna Maria Di Giacomo and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Diana Giannarelli

570 papers receiving 12.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers

2015 375 citations Luisa Carbognin, Sara Pilotto et al. profile →
Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab

2018 351 citations Diana Giannarelli et al. profile →

Peers

Countries citing papers authored by Diana Giannarelli

Since Specialization

Citations

This map shows the geographic impact of Diana Giannarelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana Giannarelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana Giannarelli more than expected).

Fields of papers citing papers by Diana Giannarelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diana Giannarelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana Giannarelli. The network helps show where Diana Giannarelli may publish in the future.

Co-authorship network of co-authors of Diana Giannarelli

This figure shows the co-authorship network connecting the top 25 collaborators of Diana Giannarelli. A scholar is included among the top collaborators of Diana Giannarelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diana Giannarelli. Diana Giannarelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Feasibility of single step hysteroscopic myomectomy: fibroid size is the most significant factor based on data from a single centre and surgeon 2025 ·Facts Views and Vision in ObGyn ·Ursula Catena, (unknown), Diana Giannarelli, (unknown), (unknown), (unknown), (unknown), Francesco Fanfani, Giovanni Scambia	0
2	The likelihood of being helped or harmed as a patient-centred tool to assess ALK-Inhibitors clinical impact and safety in ALK-addicted non-small cell lung cancer: A systematic review and sensitivity-analysis 2024 ·Cancer Treatment and Research Communications ·(unknown), (unknown), Emanuele Vita, (unknown), (unknown), Armando Orlandi, Gennaro Daniele, Diana Giannarelli, Giampaolo Tortora, Emilio Bria	3
3	Distribution and prognostic role of BRCA status in elderly ovarian cancer patients 2024 ·Gynecologic Oncology ·Lucia Tortorella, Serena Cappuccio, Diana Giannarelli, Camilla Nero, Cláudia Marchetti, Valerio Gallotta, Barbara Costantini, Tina Pasciuto, Angelo Minucci, Anna Fagotti, Giovanni Scambia	1
4	Expanding the Use of HIPEC in Ovarian Cancer at Time of Interval Debulking Surgery to FIGO Stage IV and After 6 Cycles of Neoadjuvant Chemotherapy: A Prospective Analysis on Perioperative and Oncologic Outcomes 2024 ·Annals of Surgical Oncology ·Valentina Ghirardi, (unknown), (unknown), Diana Giannarelli, Francesco Santullo, Barbara Costantini, (unknown), Camilla Panico, Luciano Frassanito, Giovanni Scambia, Anna Fagotti	4
5	Arthroscopic management of isolated partial‐thickness rotator cuff tears 2024 ·Knee Surgery Sports Traumatology Arthroscopy ·Umile Giuseppe Longo, (unknown), Alberto Lalli, (unknown), Diana Giannarelli, Miguel Ángel Ruiz Ibán	3
6	MOREOVER: multiomics MR-guided radiotherapy optimization in locally advanced rectal cancer 2024 ·Radiation Oncology ·Luca Boldrini, Giuditta Chiloiro, (unknown), Angela Romano, (unknown), (unknown), Francesco Bono, (unknown), Loris Riccardo Lopetuso, Maria De Bonis, Angelo Minucci, Luciano Giacò, Davide Cusumano, Lorenzo Placidi, Diana Giannarelli, Evis Sala, Maria Antonietta Gambacorta	6
7	Prevalence of BTK and PLCG2 Mutations in BTK Inhibitor Treated CLL Patients Who Experience Disease Progression: A Meta-Analysis 2024 ·Blood ·S. Molica, David Allsup, Diana Giannarelli	1
8	Randomized phase 2 study of valproic acid combined with simvastatin and gemcitabine/nab-paclitaxel-based regimens in untreated metastatic pancreatic adenocarcinoma patients: the VESPA trial study protocol 2024 ·BMC Cancer ·Alfredo Budillon, Alessandra Leone, (unknown), Lucrezia Silvestro, (unknown), Federica Iannelli, Maria Serena Roca, Marina Macchini, Francesca Bruzzese, Laura García‐Bermejo, Mercedes Rodríguez Garrote, Giampaolo Tortora, Michele Stanislaw Milella, Michele Reni, Claudia Fuchs, (unknown), Christine Kubiak, Elena Di Gennaro, Diana Giannarelli, Antonio Avallone	3
9	Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey 2024 ·Journal of Gynecologic Oncology ·Innocenza Palaia, Giuseppe Caruso, Violante Di Donato, (unknown), Antonella Savarese, Giorgia Perniola, (unknown), Andrea Giannini, (unknown), Giorgio Bogani, Federica Tomao, Diana Giannarelli, (unknown), (unknown), Ludovico Muzii, Sandro Pignata, (unknown)	4
10	The impact of different FLT3-inhibitors on overall survival of de novo acute myeloid leukemia: A network meta-analysis 2024 ·Leukemia Research ·Matteo Molica, Salvatore Perrone, Marco Rossi, Diana Giannarelli	1
11	Meta-analysis of the prognostic impact of TP53 co-mutations in EGFR-mutant advanced non-small-cell lung cancer treated with tyrosine kinase inhibitors 2023 ·Critical Reviews in Oncology/Hematology ·Miriam Grazia Ferrara, Lorenzo Belluomini, (unknown), Marco Sposito, Alice Avancini, Diana Giannarelli, Michèle Milella, Sara Pilotto, Emilio Bria	14
12	1084MO Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial 2023 ·Annals of Oncology ·Anna Maria Di Giacomo, (unknown), Michele Del Vecchio, Pier Francesco Ferrucci, Michele Guida, Pietro Quaglino, Massimo Guidoboni, Paolo Marchetti, (unknown), Giovanni Amato, Alessia Covre, Roberto Camerini, Luana Calabrò, Monica Valente, Mario Mandalà, Diana Giannarelli, Michele Maio	2
13	Conservative Surgery in cT4 Breast Cancer: Single-Center Experience in the Neoadjuvant Setting 2023 ·Cancers ·Antonio Franco, Alba Di Leone, Alessandra Fabi, Paolo Belli, Luisa Carbognin, (unknown), Fabio Marazzi, (unknown), Antonino Mulè, Armando Orlandi, Antonella Palazzo, Ida Paris, Alessandro Rossi, Lorenzo Scardina, Daniela Terribile, (unknown), Diana Giannarelli, Giovanni Scambia, Riccardo Masetti, Gianluca Franceschini	0
14	#759 Comprehensive cancer genomic profiling in matched primary tumor and brain metastasis samples of ovarian cancer patients: a single-institution case series 2023 ·(unknown), Camilla Nero, Maria De Bonis, Cláudia Marchetti, Angelo Minucci, (unknown), Pier Paolo Mattogno, Alessia Piermattei, Luciano Giacò, Alessandro Olivi, Diana Giannarelli, Anna Fagotti, Giovanni Scambia	1
15	SBRT in 3 Fractions for T1 Glottic Cancer 2023 ·International Journal of Radiation OncologyBiologyPhysics ·Giuseppe Sanguineti, (unknown), Marta Bottero, Alessia Farneti, Diana Giannarelli, Alessio Signori, Valeria Landoni	1
16	2022-RA-972-ESGO Quality of life in patients with advanced ovarian cancer after primary debulking surgery versus neoadjuvant chemotherapy: results from the randomized SCORPION Trial 2022 ·International Journal of Gynecological Cancer ·Cláudia Marchetti, Giovanni Scambia, Diana Giannarelli, Giuseppe Vizzielli, Maria Gabriella Ferrandina, Lucia Tortorella, Francesco Fanfani, Barbara Costantini, Tina Pasciuto, Anna Fagotti	2
17	Primary Analysis and 4-Year Follow-Up of the Phase III NIBIT-M2 Trial in Melanoma Patients With Brain Metastases 2021 ·Clinical Cancer Research ·Anna Maria Di Giacomo, Vanna Chiarion‐Sileni, Michele Del Vecchio, Pier Francesco Ferrucci, Michele Guida, Pietro Quaglino, Massimo Guidoboni, Paolo Marchetti, Ornella Cutaia, Giovanni Amato, Alessia Covre, Roberto Camerini, Luana Calabrò, Monica Valente, Diana Giannarelli, Mario Mandalà, Michele Maio	41
18	Prevalence, incidence and associated factors of pressure injuries in hospices: A multicentre prospective longitudinal study 2020 ·International Journal of Nursing Studies ·Marco Artico, Michela Piredda, Daniela D’Angelo, Maura Lusignani, Diana Giannarelli, Anna Marchetti, (unknown), Chiara Mastroianni, Maria Grazia De Marinis	19
19	Prevention of Bortezomib-Related Peripheral Neuropathy With Docosahexaenoic Acid and α-Lipoic Acid in Patients With Multiple Myeloma: Preliminary Data 2018 ·Integrative Cancer Therapies ·Marta Maschio, Alessia Zarabla, Andrea Maialetti, Francesco Marchesi, Diana Giannarelli, (unknown), Francesco Pisani, Daniela Renzi, Edvina Galiè, Andrea Mengarelli	24
20	Short- and long-term effects of 186Re-1,1-hydroxyethylidene diphosphonate in the treatment of painful bone metastases. 2000 ·PubMed ·Rosa Sciuto, A. Tofani, Anna Festa, Diana Giannarelli, Rosella Pasqualoni, C.L. Maini	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact